Entera Bio raises $275m for Phase III osteoporosis drug trial
Israeli drug development company Entera Bio (Nasdaq: ENTX) has announced a $275 million private placement. Prior to the announcement ...
Wednesday, August 26, 2026
Tag: BIO
Nuvation Bio expects gross-to-net to stabilize around 30% as IBTROZI shifts to >50% TKI-naive starts (NYSE:NUVB)
Earnings Call Insights: Nuvation Bio (NUVB) Q1 2026 Management View Dr. David Hung said the launch is being driven by ...
Boundless Bio Inc (BOLD) Q4 2025 Earnings Results
Earnings Per Share (GAAP) $-0.58 estimate N/A Revenue $17.3M estimate N/A Loss narrows sequentially. Boundless Bio Inc reported a loss ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.